Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9054539 | 0.83 | ALDH1A1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL3425052 | 0.81 | — | — | |
| SCHEMBL35753 | 0.81 | — | — | |
| SCHEMBL177842 | 0.79 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL1580122 | 0.79 | — | — | |
| SCHEMBL5465330 | 0.79 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL7929800 | 0.77 | ZDHHC20 (0.33) | ALDH1A1 | |
| SCHEMBL2445448 | 0.77 | — | — | |
| SCHEMBL7938767 | 0.77 | ZDHHC20 (0.33) | ALDH1A1 | |
| SCHEMBL7795037 | 0.77 | ZDHHC20 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9078021-A | — | — | None | — | — | JP | disclosed |
| JP-10017622-A | — | — | None | — | — | JP | disclosed |
| JP-3227310-A | — | — | None | — | — | JP | disclosed |
| US-20260015577-A1 | COMPOSITION FOR 3D PRINTING SUPPORT OR 3D CELL CULTURE SUPPORT | JSR CORPORATION (JP) | 2026-01-15 | — | — | US | disclosed |
| WO-2024014377-A1 | COMPOSITION FOR 3D PRINTING SUPPORT OR 3D CELL CULTURE SUPPORT | JSR株式会社 | 2024-01-18 | — | — | WO | disclosed |
| US-20070004890-A1 | N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof | PITTSBURGH- OF THE COMMONWEALTH SYSTEMS OF HIGHER EDUCATION, UNIVERSITY OF | 2007-01-04 | — | — | US | disclosed |
| US-7135598-B2 | N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof | UNIVERSITY OF PITTSBURGH (US) | 2006-11-14 | — | — | US | disclosed |
| US-20040167338-A1 | N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof | UNIVERSITY OF PITTSBURGH | 2004-08-26 | — | — | US | disclosed |
| WO-2004022524-A9 | N-VINYLFORMAMIDE DERIVATIVES, POLYMERS FORMED THEREFROM AND SYNTHESIS THEREOF | UNIV PITTSBURGH (US) | 2004-06-24 | — | — | WO | disclosed |
| EP-0990667-B1 | Porous copolymer particles, process for preparing the same and use of the same | SHOWA DENKO KK (JP) | 2004-05-12 | — | — | EP | disclosed |
| US-5407996-A | Contacting with an aqueous solution of metal ion or metal oxide to form a gel; calcining | SHOWA DENKO K.K. (JP) | 1995-04-18 | — | — | US | disclosed |
| US-5344655-A | Drug delivery | SHOWA DENKO K.K. (JP) | 1994-09-06 | — | — | US | disclosed |
| US-5338815-A | Used in thickeners, dispersion stabilizers and lubricants | SHOWA DENKO K.K. (JP) | 1994-08-16 | — | — | US | disclosed |
| US-5300606-A | Crosslinked N-vinylamide resin | SHOWA DENKO K.K. (JP) | 1994-04-05 | — | — | US | disclosed |
| US-5280095-A | N-vinylcarboxylic acid amine resin | SHOWA DENKO K.K. (JP) | 1994-01-18 | — | — | US | disclosed |
| US-5254338-A | N-vinylacetamide polymer | SHOWA DENKO K.K. (JP) | 1993-10-19 | — | — | US | disclosed |
| EP-0510246-A1 | Use of fine particulate crosslinked type n-vinylamide resin microgel | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1992-10-28 | — | — | EP | disclosed |
| EP-0473881-A1 | Liquid absorption agent | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1992-03-11 | — | — | EP | disclosed |
| JP-H03227310-A | N,N'-METHYLENEBIS(N-VINYLALKYLAMIDE) AND CROSSLINKABLE POLYMER PRODUCED THEREFROM | SHOWA DENKO KK | 1991-10-08 | — | — | JP | disclosed |
| EP-0446636-A2 | External application base or auxiliary agent and external application composition for human being or animal containing the same | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1991-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015577-A1 | COMPOSITION FOR 3D PRINTING SUPPORT OR 3D CELL CULTURE SUPPORT | BOD1L1, HTR3D, BPNT1 | ALDH1A1 1413/4885TSHR 4116/4885 |
| US-20040167338-A1 | N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof | FFAR3, FFAR1, FFAR2 | ALDH1A1 3165/4885TSHR 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.